Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Launch Of Donepezil Hydrocholride Tablets


Saturday, 27 Jul 2013 03:58am EDT 

Dr.Reddy's Laboratories Ltd announced that it has launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ARICEPT, 23 mg in the US market on July 26, 2013, following the approval by the United States Food and Drug Administration (USFDA) of Dr.Reddy's ANDA for Donepezil Hydrochloride Tablets, 23 mg. 

Company Quote

3218.4
30.65 +0.96%
19 Sep 2014